Evidence map›Paper›PMID 37490295›Full record

ArticleClinical journal of the American Society of Nephrology : CJASN2023

Racial and Ethnic Disparities and Facility-Level Variation in GLP-1 RA Prescription among US Veterans with CKD.

L Parker Gregg, Melandrea L Worsley, David J Ramsey, Matthew W Segar, Michael E Matheny, Salim S Virani, Sankar D Navaneethan

Open access · greenAbstract readLetter
In one paragraph

Article in Clinical journal of the American Society of Nephrology : CJASN, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.4field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Achieving equitable access to incretin-based therapies in cardiovascular care.American heart journal plus : cardiology research and practice · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

L Parker GreggSection of Nephrology , Baylor College of Medicine , Selzman Institute for Kidney Health , Houston , Texas.
Melandrea L WorsleySection of Nephrology , Baylor College of Medicine , Selzman Institute for Kidney Health , Houston , Texas.ORCID 0000-0002-6801-2847
David J RamseyMichael E. DeBakey VA Medical Center Health Services Research and Development , Center for Innovations in Quality, Effectiveness and Safety , Houston , Texas.ORCID 0000-0002-5651-3660
Matthew W SegarDepartment of Cardiology , Texas Heart Institute , Houston , Texas.ORCID 0000-0001-6100-0897
Michael E MathenyGeriatrics Research Education and Clinical Care Service , Tennessee Valley Healthcare System VA, Nashville , Tennessee.ORCID 0000-0003-3217-4147
Salim S ViraniDepartment of Cardiology , Texas Heart Institute , Houston , Texas.ORCID 0000-0001-9541-6954
Sankar D NavaneethanSection of Nephrology , Baylor College of Medicine , Selzman Institute for Kidney Health , Houston , Texas.
Michael E. DeBakey VA Medical Center · USAga Khan University · PKBaylor College of Medicine · USVA Tennessee Valley Healthcare System · US

Funding

Research Training Program in Cardiovascular SurgeryT32HL139430 · NHLBI · BAYLOR COLLEGE OF MEDICINE · PI Todd K Rosengart · 2018 to 2026
$2.9M
MENTORED PATIENT-ORIENTED RESEARCH TOWARDS OPTIMIZING CARDIOVASCULAR OUTCOMES IN CHRONIC KIDNEY DISEASEK24HL161414 · NHLBI · BAYLOR COLLEGE OF MEDICINE · PI Sankar Dass Navaneethan · 2022 to 2026
$588k
Improving Analysis of Endogenous Multimodal Treatments for Use in Geriatrics Health Outcomes StudiesI01HX002237 · VA · VA BOSTON HEALTH CARE SYSTEM · PI GARRIDO, MELISSA M · 2018 to 2021
–
Optimizing Renin Angiotensin System Blocker Use among Veterans with Kidney DiseaseI01HX002917 · VA · MICHAEL E DEBAKEY VA MEDICAL CENTER · PI NAVANEETHAN, SANKAR DASS, VIRANI, SALIM S · 2020 to 2025
–
Association of diuretics with change in extracellular volume, natriuretic peptides, symptoms, and cardiovascular outcomes in CKDIK2CX002368 · VA · MICHAEL E DEBAKEY VA MEDICAL CENTER · PI Lucile Parker Gregg · 2022 to 2027
–
CSRD VA IK2 CX002368HSRD VA I01 HX002917HSRD VA SDR 02-237NHLBI NIH HHS K24 HL161414NHLBI NIH HHS K24 HL161414-01ANHLBI NIH HHS T32 HL139430
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Renal Insufficiency, ChronicVeteransEthnicityHealthcare DisparitiesHumansRacial GroupsUnited States

Identifiers

PMID37490295
PMCPMC10637447
OpenAlexW4385230362

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.